chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a major multi-day painful gout flare right knee; a major multi-day painful gout flare right knee; This is a spontaneous report from a contactable other-hcp (patient). A 51-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9264, Expiry date: unknown, at the age of 51 years), dose 2 via an unspecified route of administration, administered in Arm Left on 02Feb2021 15:15 as dose 2, single for covid-19 immunisation administered at Hospital. Medical history included obesity, hypertension and high uric acid. The concomitant medications were not reported. Historical vaccine included bnt162b2 (Batch/Lot number: EL1289, Expiry date: unknown, at the age of 51 years), dose 1 via an unspecified route of administration, administered in Arm Left on 15Jan2021 10:00 as dose 1, single for covid-19 immunisation at hospital. Three days after first dose he experienced a mid-grade gout flare left ankle on 19Jan2021 08:00. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient experienced a major multi-day painful gout flare right knee seven days after second dose on 09Feb2021. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The reporter assessed the event as non-serious. The outcome of event was recovering.  Follow-up attempts completed. No further information expected.
Information has been received from a registered nurse (R.N.) concerning a 18-year-old male with an amoxicillin allergy (rash following amoxicillin) who on 17-NOV-1997 was vaccinated with a dose of Varivax. There was no concomitant medication. No illness at the time of vaccination. On 27-NOV-2006 the patient had a reported temperature of 102 and his first outbreak was reported on 29-NOV-2006. Subsequently, the patient recovered on 02-DEC-2006. Additional information has been requested.
Pt. presented to New Hire Orientation on 2/22/2022. She presented as a healthy individual and filled out a screening form for administration of vaccines. The CMA that was administering vaccines did not see screener and missed that pt. checked that she was pregnant. Pt. denied allergies or any other vaccines received in last 4 weeks on form. CMA administered both MMR and Varicella to pt. Pt. stated that she is 2 months pregnant (approximately 8 weeks) which would put her EDD at 10/5/2022. She was advised to contact her prenatal care provider for further follow up and guidance.
Don't feel good at all; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Don't feel good at all) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Don't feel good at all). At the time of the report, MALAISE (Don't feel good at all) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported  No treatment information was provided.
Increased inflammation and arthritis symptoms. (positive ANA 4/2021)). Use Ibuprofen and Tylenol 4 to 5 times a week  to treat symptoms for past two months. Prior to vaccine use of Ibuprofen and Tylenol was 1 to 2 times/month.
This spontaneous report was received from a registered nurse concerning a 4 year old patient of unknown gender. On 04-SEP-2013, the patient was vaccinated with a dose of an improperly stored M-M-R II (lot number and expiry date were reported as H018950 and 18-OCT-2014 respectively, dose and route unspecified) which was exposed to 66 degrees Fahrenheit (F) for 41.5 hours. No concomitant therapy was reported. No adverse effects were reported. This is one of the two reports from the same source. Additional information has been requested.
Absolutely no problems after the vaccination until about 24 hours later: Then sudden onset malaise, fever, myalgias (including injection site pain which was not previously present) arthralgias, headache, nausea, malaise to the point where I could not continue to work. I went home, took 600 mg ibuprofen, 25 mg of benadryl and slept for 4 hours. I felt better when I woke up and feel good today, as if nothing happened
Patient received the Pfizer Covid-19 Vaccine at 1918. 1950 Patient reports numbness and tingling to left arm. Patient denied allergies to any previous vaccines, food, or medications. Patient stated no significant medical history. 2000 Patient reports numbness, tingling, and cold temperature from left shoulder to fingertips. Capillary refill <3 seconds. 2015 Patient reports nausea-crackers and water given by staff. 2030 Nausea resolved. Patient reports numbness, tingling, and cold temperature in bilateral feet. Elevated legs and feet. Warm blanket given.  Capillary refill <3 seconds. 2045 Patient reports numbness and tingling to right arm. 2050 Called IMT. Patient called husband to pick her up and take her to be seen by an adult physician at an outside facility. Patient transferred to vehicle by wheelchair in stable condition.   2315 Spoke to patient and she stated symptoms resolved and home resting.
Had some of the side effects; This case was reported by a consumer via interactive digital media and described the occurrence of adverse drug reaction in a male patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine at an unknown dose. On an unknown date, unknown after receiving Tdap Vaccine, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Tdap Vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. It was reported that the patient got the shot and also had some of the side effects. The case has been linked with the case US2019AMR174465, reported by same reporter.
Headache, 100+ fever, swollen lymph node, injection site redness and swelling, diarrhea, lethargic
the right side swelling, swelling underneath armpit, swelling of collarbone and neck; This is a spontaneous report from a contactable Nurse reporting for herself.    A 39-years-old female patient  received the second dose of bnt162b2 (BNT162B2; Lot # EL0142) vaccine, intramuscular on 12Jan2021 15:30 at single dose for Covid-19 immunisation.  Medical history included deep vein thrombosis, provoked DVT, and moderate asthma .  There were no concomitant medications. The patient received the first dose of BNT162B2 vaccine on 23Dec2020. The patient experienced right side swelling on 12Jan2021 some hours after injection. On 13Jan2021 swelling underneath armpit was significant, swelling of collarbone and neck was also present. The reported event was considered Important Medical event. The outcome of the event was  recovering.  The event was treated with  Round the clock Ice pack. Antihistamine and NSAIDs.  Followup information has been requested. Lot number already provided.; Sender's Comments: Based on the compatible temporal association, a contributory role of suspect vaccine BNT162B2 in the development of "the right side swelling, swelling underneath armpit, swelling of collarbone and neck" cannot be excluded. The impacts of this report on the benefit/risk profile of the product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
11 days after vaccination (8/7/2007), at 5:30-6 am. he had left-sided pressure-like chest pains radiating under his left axilla, gr.7-9/10, not related to movement. He also noted increased tiredness. No shortness of breath. It got better with 800 mg ibuprofen.  The next morning (8/8), at 2 am, he had severe, Gr. 8-10/10, sharp chest pains, non-radiating. He was admitted to Hospital under Dr.  CKMB and Troponin levels were elevated.  Heart cath on 8/8 revealed an ejection fraction of 35%. Patient is still in the hospital, so required hosp days is an estimate.
Mom called. Child has hives (+) itching (L) deltoid x 1 week after injection.
Pfizer vaccine given to a patient under 12 years of age, DOB. Spoke with parent and she stated the patient has had no adverse reactions.
pt was vax in 4/98 & in 7/98 pt devel over 100 pox, scarring, fever 101.4f & swelling.
LITTLE ITCHY BUMP BELOW THE INJECTION SITE; LITTLE ITCHY BUMP BELOW THE INJECTION SITE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced little itchy bump below the injection site, and little itchy bump below the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the little itchy bump below the injection site and little itchy bump below the injection site was not reported. This report was non-serious.
1 week after first dose - eczema flare up. Welts in armpits (worse on left side) and entire body itches. This lasted for about a month. I went to the doctor multiple times. I received steroid cream, topical creams, recommended benadryl and was told it was eczema. I have never had an eczema flare up before or been diagnosed with eczema in the past. I received the booster on 10/8/2021 and now (10/20/21), I am beginning to have welts in armpits and an itchy body.
Resident found unresponsive in her room. Note from earlier: Resident appears to be weak today. Resident ate a few bites of dinner before refusing the tray. Writer encouraged fluids. Vitals 123/72 80HR BS 166. Will log for Doctor and continue to monitor. Was sent out 911.
Patient stated that within a few hours of receiving the vaccine she developed "mild cold like symptoms".  She stated she did not ever have a fever but did have a sore throat, congestion, tiredness and "burning in both eyes - the burning was from the inside out and lasted several days". The patient stated that the cold symptoms "got worse" after about 2 weeks.  The patient stated that about the same time that the cold symptoms got worse she began to develop "nerve pain when biting down".  She stated this symptom only lasted for about 3 days.  She described the pain as "when I would bite down I felt a sharp shooting pain clear up into my left eye". The patient stated she has had shingles x 2 in the past which she describes were along the nerves across the top of the left side of the top of her head.  The patient is unclear if the vaccine perhaps caused some nerve irritation or perhaps she was "predisposed" to nerve irritation because of her history.  The patient stated all of her symptoms including the nerve pain have resolved completely without residual but she is wondering if she should ever get the Flumist vaccine again.
The patient experienced no symptoms; she accidentailly administered the PROQUAD (lot S012535, expiration 10/20/2020) to the patient because PROQUAD and MMR II both have the same blue cap, the same blue lettering and are both stored in the freezer; she accidentailly administered the PROQUAD (lot S012535, expiration 10/20/2020) to the patient because PROQUAD and MMR II both have the same blue cap, the same blue lettering and are both stored in the freezer; on 7/8/2020 she administered a dose of PROQUAD (lot S012535, expiration 10/20/2020) and a dose of VARIVAX; This spontaneous report was received from a medical assistant and refers to a 15-month-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 08-JUL-2020, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot # S012535, expiration date: 20-OCT-2020, subcutaneously (exact dose and injection site were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) lot # reported as S02131 (upon internal verification lot # was determined to be not valid), expiration date reported as 09-JUL-2021 (exact dose, injection site and route of administration were not provided) both for prophylaxis. The reporter stated, she had intended to administer a dose of varicella virus vaccine live (oka/merck) (VARIVAX) and a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), but she accidentally administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) to the patient because measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) both had the same blue cap, the same blue lettering and are both were stored in the freezer. The patient experienced no symptoms.
It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
This spontaneous report as received from a licensed practical nurse refers to a 16 month old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. The nurse reported that, on 23-DEC-2014, the patient was vaccinated with (Oka/Merck) VARIVAX INJ that was improperly stored (0.5 ml once, subcutaneously; lot number not provided). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
I was notified by a tech that a patient had fainted in the aisle outside the vaccine room. I asked another pharmacist to call EMS and left the pharmacy to check on the patient. Patient's mom was sitting with patient's head in her lap, says she was able to catch her so she did not hit her head. Asked another employee to grab a manager and a non-diet soda and to watch out for and direct EMS. I brought a chair to prop up patient's legs and eventually have her sit when she felt comfortable. Patient was warm, brought her an ice pack and soda, removed her outer sweatshirt. Patient remained conscious and continued to improve until EMS arrived on the scene where they took her vitals and monitored her further.
Palpitations, runs of tachycardia, exertional dyspnea.
Pt. states that her arm became quite swollen, red and itchy after receiving HPV dose #3.She noted the symptoms on 5/14/08 and are persisting until today (5/16/08). Pt has applied ice packs to swelling over bicep area. Advised to cont. w/ ice packs, Benadryl and pain reliever. To return to clinic if S/Sx persist.
severe chills; muscle aches; fever; arm "a little sore"; freezing to death; she is very tired; joints bothering her; This is a spontaneous report from a contactable Consumer (Patient) via Medical information team. An 82-year-old female patient received the first dose of bnt162b2 (BNT162B2, Pfizer-BIONTECH covid-19 vaccine, Formulation: Solution for injection, Lot number: EN9581, Expiration date: May2021, NDC number was not provided) via an unspecified route of administration, in arm right on 06Feb2021 18:00 as single dose for covid-19 immunisation. Medical history included thyroid condition and covid-19 from 29Jun2020 to an unknown date. Concomitant medication were not reported. Patient got 1st dose of vaccine on 06Feb2021. After dose experienced severe chills, muscle aches on 07Feb2021, fever, arm "a little sore", "freezing to death" on Feb2021, patient says, "the same symptoms like I had covid" patient tested positive for covid 19 in Jun, antibodies present before vaccine (in Dec). Patient was calling about the Covid 19 Vaccine. She had the first shot on Saturday at 6 o clock. She then woke up at like 3 or 4 in the morning with severe chills. Patient states that she had covid back Jun2020, on 29Jun2020 she was diagnosed as positive, she took herself to the hospital. She recalls getting the test 4 days later. The back around Christmas 2019 she a lot of similarities to it. After 4 days she recalls during a weekend she got sick. She recalls going on a Monday to get her test done, it did come back positive, she served her time, and proceeded to get better. Patient confirms that her First Dose of the covid vaccine was on Saturday 06Feb2021 at 6PM. Then at 3 or 4AM on 07Feb2021 she began to notice chills. Patient has the side effect list she had all of them, on Sunday she just slept all day long, her back and head was killing her, patient states that it felt as if she had covid again, patient experienced the same symptoms as when patient had covid. Patient no longer has the severe chills, that was Sunday into Monday. Patient then clarifies that she did not mean her back and head killing her, its more muscle aches and joints bothering her, and patient had a fever, patient is not having muscles aching at the moment, it normal very minimal, she is very tired on Feb2021. Patient second dose is on 27Feb2021. Patient takes a thyroid pill but doesn't know what name of her thyroid condition is. patient blood pressure is good. Patient explains that back in Jun2020, she was Sick for 4-5 days she then took a covid test, tested by Nasal Swab and then got the results the next day. 29Jun2020 is the day of the test, on the same day she went to the hospital but got sent home in 6 hours. In Dec2020 she had a positive antibody covid test. The outcome of the event severe chills was recovered on 08Feb2021, muscle aches was recovering and unknown for other events.
threw up about 3 hours ago; fever which started last night; This is a spontaneous report from a contactable other healthcare professional (reporting for herself). A female patient (Age: 22; Units: unknown) received bnt162b2 (also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were unknown), via an unspecified route of administration on 23Dec2020 11:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got Covid vaccine yesterday at around 1130 am and had fever which started last night (23Dec2020) and "threw up" about 3 hours ago this morning (24Dec2020) and mentioned that it was just on 1 occasion, but it was a lot. She wanted to know if it's normal. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Had a biopsy and it came back as shingles/ Rash, full breakout, nerve pain; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6207, Expiration date was not reported), via an unspecified route of administration (administered on the left upper arm) on 15Mar2021 08:30 (at the age of 72-year-old) as 1st dose, single for COVID-19 immunisation (reported as "so she wouldn't get covid"). Medical history included open heart surgery from an unknown date. Concomitant medications included spironolactone (ALDACTONE) from 2019 (reported as 2 years ago) and ongoing, taken for an unspecified indication; bisoprolol fumarate (ZEBETA), atorvastatin (LIPITOR) and apixaban (ELIQUIS) all taken for an unspecified indication, start and stop dates were not reported. It was also reported that the patient was taking unspecified blood thinners. The patient has no history of all previous immunization with the Pfizer vaccine. The patient has no reported adverse event prior to vaccination.The patient didn't take any vaccine within 4 weeks prior to the Covid vaccine. The patient has no family medical history relevant to the adverse events. On 17Mar2021 18:00, the patient experienced rash. The patient had full breakout on 18Mar2021. The patient also reported that she has quite a bit of residual nerve pain and was unsure if it started probably whether on 18Mar2021 or 19Mar2021. The patient had a biopsy and it came back as shingles. The patient experienced shingles on 17Mar2021 18:00. The patient underwent lab tests and procedures in a dermatology clinic at a University on 23Mar2021 which included biopsy: positive for shingles. The adverse events result in physician office visit on 18Ma2021 and 23Mar2021. Therapeutic measures were taken as a result of the event included steroid cream, lidocaine spray, ice, Tylenol and Tylenol with Norco for pain. The patient reported that the rash has been going away, not much left, about a quarter left, like 25% maybe left and the nerve pain changes. The outcome of the event was not recovered.   No follow-up attempts needed. No further information is expected.
itching rash, tingling and warming sensation in arm radiating down within 15 min of shot. Pt has history of several allergic reactions to foods and medications. Stated that this felt like a similar reaction. Provided OTC Benadryl and patient stated that it resolved fairly quickly after initial dose, but had to continue w/ Benadryl for 2 days afterwards otherwise rash would reemerge.
Patient came in with redness and swelling from shoulder down past elbow. Significant swelling shown just below elbow but no pain or discomfort reported.
within 45 minutes my face turned bright red and felt very warm lasted for a day and a half otherwise felt fine